Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q3 2024 Earnings

7AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-1.06

-0.71

-0.35

0

Details

Expected EPS

-0.576825

Actual EPS

-0.41

Surprise EPS

0.17

Surprise Percent

+28.92%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -0.41 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.